YANG Chunhong, AN Ling, ZHANG Song, LIU Chunrong, CHEN Yong, YANG Fengzhong. Minimally invasive soft channel puncture and drainage versus removal of hematoma by craniotomy in the treatment of hypertensive intracerebral hemorrhage[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 66-68,72. DOI: 10.7619/jcmp.202017017
Citation: YANG Chunhong, AN Ling, ZHANG Song, LIU Chunrong, CHEN Yong, YANG Fengzhong. Minimally invasive soft channel puncture and drainage versus removal of hematoma by craniotomy in the treatment of hypertensive intracerebral hemorrhage[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 66-68,72. DOI: 10.7619/jcmp.202017017

Minimally invasive soft channel puncture and drainage versus removal of hematoma by craniotomy in the treatment of hypertensive intracerebral hemorrhage

More Information
  • Received Date: June 27, 2020
  • Available Online: September 29, 2020
  • Objective To compare the effect of minimally invasive soft channel puncture as well as drainage and removal of hematoma by craniotomy in the treatment of hypertensive intracerebral hemorrhage. Methods Totally 116 patients with hypertensive intracerebral hemorrhage were divided into control group and observation group by blind selection method, with 58 cases in each group. The control group was treated with removal of hematoma by craniotomy, and the observation group was treated with minimally invasive soft channel puncture and drainage. The operation related indexes, score of Barthel index and incidence of complications were compared between the two groups. Results The operation time, hematoma clearance time and cerebrospinal fluid recovery time in the observation group were significantly shorter than those in the control group(P<0.05). The scores of Barthel index in the observation group at 1 month, 3 and 6 months after operation were significantly lower than those in the control group(P<0.05). The incidence of complications in the observation group was 6.90%, which was significantly lower than 20.69% in the control group(P<0.05). Conclusion Minimally invasive soft channel puncture and drainage is effective in the treatment of hypertensive intracerebral hemorrhage, which can shorten operation time, reduce blood loss, accelerate postoperative recovery and reduce incidence of complications.
  • 李邦安, 李春国, 汪守法, 等. 微创软通道穿刺引流术与开颅血肿清除术治疗高血压性脑出血80例的疗效观察[J]. 神经损伤与功能重建, 2020, 15(5): 288-289

    , 307.
    陈和安, 石全红. 软通道微创穿刺抽吸引流术治疗对高血压性脑出血患者神经功能损伤及血肿清除率的影响[J]. 湖南师范大学学报: 医学版, 2019, 16(6): 163-165.
    刘杰文, 宋畅. 高血压性脑出血软通道微创穿刺治疗与开颅血肿清除术疗效比较[J]. 中西医结合心脑血管病杂志, 2019, 17(7): 1104-1105.
    张呈祥. 用立体定向软通道微创血肿穿刺外引流术治疗高血压性脑出血的效果分析[J]. 当代医药论丛, 2017, 15(12): 38-40.
    冯良应, 钟元冠, 林宗保. 立体定向微创软通道穿刺血肿引流术治疗高血压性脑出血对患者神经功能影响[J]. 中国医师杂志, 2020, 22(2): 281-283.
    李志勇. 改良立体定向软通道微创穿刺引流术对高血压 壳核脑出血术后神经功能及日常生活能力的影响[J]. 中西医结合心脑血管病杂志, 2020, 18(3): 508-511.
    龚金兵, 张占伟, 张蕾, 等. 微创软通道穿刺引流术治疗高血压性重症脑干出血的疗效观察[J]. 中国微侵袭神经外科杂志, 2020, 25(3): 124-125.
    聂晓枫. 脑心通胶囊辅助立体定向软通道微创血肿穿刺外引流术治疗高血压性脑出血疗效观察[J]. 中国药业, 2018, 27(19): 31-33.
    李嘉, 王全力, 刘亚坤, 等. 氨甲环酸联合开颅血肿清除术治疗中等量基底核区高血压性脑出血临床研究[J]. 中国药业, 2020, 29(10): 130-132.
    LI H, XU H C, WEN H Y, et al. Overexpression of LH3 reduces the incidence of hypertensive intracerebral hemorrhage in mice[J]. J Cereb Blood Flow Metab, 2019, 39(3): 547-561.
    崔冬强, 冯铭, 束旭俊, 等. 增强现实技术辅助神经内镜与小骨窗开颅血肿清除术治疗高血压性脑出血疗效分析[J]. 中国现代神经疾病杂志, 2019, 19(9): 654-660.
    龙海成. 用微创颅内血肿清除术与开颅血肿清除术治疗高血压性脑出血的疗效对比[J]. 当代医药论丛, 2020, 18(6): 95-97.
    廖恺, 曹亚琨, 余斐. 硬通道微创穿刺引流术在高血压性脑出血患者中的应用及再出血影响因素研究[J]. 当代医学, 2020, 26(4): 110-112.
    王小刚, 朱伟杰. 钻孔置管引流与内镜下微创手术治疗高血压性脑出血的效果及术后神经功能对照的临床研究[J]. 中国医师杂志, 2019, 21(11): 1701-1703.
    刘杰文, 宋畅. 高血压性脑出血软通道微创穿刺治疗与开颅血肿清除术疗效比较[J]. 中西医结合心脑血管病杂志, 2019, 17(7): 1104-1105.
    姚俊恒, 高永峰. 微创定向钻孔软通道血肿穿刺引流术治疗高血压性脑出血临床疗效观察[J]. 首都食品与医药, 2020, 27(10): 26-26.
  • Related Articles

    [1]XU Jingchun, DAI Guihong, WANG Lu, ZHU Xiaowei, YU Hong. Research progress of trichorhinophalangeal syndrome type 1 in breast cancer[J]. Journal of Clinical Medicine in Practice, 2025, 29(6): 143-148. DOI: 10.7619/jcmp.20244478
    [2]CHEN Shaolan, LUO Jun, PENG Shusheng, RAN Jing, YOU Xianhui. Mechanism of aprepitant in reversing chemoresistance in colorectal cancer mice through endoplasmic reticulum stress[J]. Journal of Clinical Medicine in Practice, 2025, 29(2): 69-74. DOI: 10.7619/jcmp.20244608
    [3]ZHU Guanghao, ZHU Minhui, ZHENG Hongliang. Research progress on the role of long non-coding RNA in regulating cancer radiosensitivity[J]. Journal of Clinical Medicine in Practice, 2024, 28(16): 142-148. DOI: 10.7619/jcmp.20240768
    [4]WANG Man, ZHOU Jie, YAN Xuebing, WANG Chenghai. Long non-coding RNA-PVT1 promotes migration and metastasis of renal carcinoma cells[J]. Journal of Clinical Medicine in Practice, 2023, 27(20): 39-47. DOI: 10.7619/jcmp.20232544
    [5]WANG Zhongqiao, GAO Yan, SI Fengzhi. Experimental study of microRNA-155-5p regulating epithelial mesenchymal transformation of nasal mucosal epithelial cells by targeting histone deacetylase 1[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 14-19. DOI: 10.7619/jcmp.20221520
    [6]WANG Jing, ZHOU Bei, WU Zhong, WU Chenhao. Mechanism of microRNA-141 regulates epithelial-mesenchymal transition in breast cancer by targeting epidermal growth factor receptor[J]. Journal of Clinical Medicine in Practice, 2022, 26(19): 14-21. DOI: 10.7619/jcmp.20221276
    [7]SUN Yaocheng, TANG Jianjun, WEI Lai, HANG Suning, CANG Jie, WANG Mengtao, XI Jianbo. Effects of ALKBH5 on epithelial-mesenchymal transition in human hepatoma cell[J]. Journal of Clinical Medicine in Practice, 2022, 26(15): 69-74. DOI: 10.7619/jcmp.20220435
    [8]DENG Lin, XIE Luli, LI Kun. Effects of long non-coding RNA LINC01139 in regulating proliferation, migration and invasion of oral squamous cell carcinoma cisplatin-resistant cells by targeting microRNA-300[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 86-90. DOI: 10.7619/jcmp.20214197
    [9]JIANG Weihua, YI Lina, ZHANG Chenguang, Xuelaiti·PAIZULA, XU Wenting, OU Jianghua. Expression of mesenchymal-epithelial transition factor and fatty acid synthase in triple-negative breast cancer and their impacs on prognosis[J]. Journal of Clinical Medicine in Practice, 2021, 25(8): 16-20. DOI: 10.7619/jcmp.20210355
    [10]SHAO Weibin, LU Ping, XIA Chunying, LI Xin, XUN Kang, FENG Songtao, ZHAO Qian. The role of microRNA-192 in progression of advanced glycation end products-induced epithelial-to-mesenchymal transition of human peritoneal mesothelial cells[J]. Journal of Clinical Medicine in Practice, 2017, (19): 95-98. DOI: 10.7619/jcmp.201719027
  • Cited by

    Periodical cited type(16)

    1. 张清,张玉君. 经阴道超声联合血清β-hCG、孕酮检测诊断异位妊娠价值. 中国计划生育学杂志. 2025(02): 361-365 .
    2. 王艳. 宫外孕诊断中阴道超声与腹部超声联合检查的作用. 吉林医学. 2024(04): 829-832 .
    3. 朱见开,田爱红,刘肖莲. 经阴道联合经腹异位妊娠患者超声特点与血清β-hCG, 雌孕激素的关系. 现代医用影像学. 2024(02): 381-384 .
    4. 魏巍. 彩色多普勒超声对卵巢黄体破裂与宫外孕破裂的鉴别诊断价值. 中国现代药物应用. 2024(10): 75-77 .
    5. 刘玉净,鲁育民,胡金花,黄菊霞,余奕,程扬眉. 经阴道三维彩超联合血β-人绒毛膜促性腺激素对早期宫外孕的诊断价值. 中国性科学. 2024(07): 79-82 .
    6. 华桂红,朱秀梅,刘丽君. 探讨阴道超声联合腹部超声对宫外孕的诊断价值. 世界复合医学. 2023(01): 103-106 .
    7. 朱喜刚,王红霞,董刚. 阴道超声联合腹部超声诊断宫外孕的临床有效性研究. 江苏卫生保健. 2023(03): 159-160 .
    8. 徐春波. 异位妊娠经腹与阴道超声诊断的临床应用价值分析. 中国卫生标准管理. 2022(01): 65-68 .
    9. 白雪. 阴道超声联合腹部B超在宫外孕诊断上的应用价值. 影像研究与医学应用. 2022(04): 58-60 .
    10. 何旻昉. 经阴道超声与经腹部超声诊断宫外孕的准确度及预测价值比较. 影像研究与医学应用. 2022(10): 158-160 .
    11. 曾艳梅,唐文娟. 阴道超声联合腹部B超在异位妊娠诊断上的应用. 基层医学论坛. 2022(22): 86-88 .
    12. 张丽贞. 经阴道超声诊断宫外孕的临床价值及准确性分析. 现代医用影像学. 2022(08): 1551-1554 .
    13. 顾琼. 阴道超声联合腹部B超对宫外孕的诊断价值. 世界复合医学. 2022(10): 52-54+62 .
    14. 吴艳萍. 经阴道彩超检查子宫及输卵管血流参数对早期输卵管妊娠诊断的意义. 黔南民族医专学报. 2022(04): 243-245 .
    15. 焦扬. 经阴道彩超对未破裂型宫外孕超声诊断的价值分析. 实用妇科内分泌电子杂志. 2022(16): 95-97 .
    16. 皮苏芹,张艳. 经腹与经阴道彩超联合检查在异位妊娠诊断中的价值分析. 影像研究与医学应用. 2021(21): 123-124 .

    Other cited types(0)

Catalog

    Article views (585) PDF downloads (10) Cited by(16)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return